Human Organ on a Chip: A Better Model for Drug Development?

Reading time: 5 minutes Kaye Alcedo Even before President Nixon’s declaration of the “war on cancer” in 1971, the journey towards a cure was nothing but a rollercoaster ride. Many promising cancer drugs are tested in human clinical trials but ultimately fail primarily because they demonstrate inadequate efficacy or safety, costing billions of dollars, increasing …

Towards Personalized Cancer Medicine for All

Reading time: 6 minutes Rachel Cherney Modern medicine has saved millions of lives, but with a little improvement, it could save even more. Our current medical practices rely on medical professionals reacting to a diagnosis, treating patients after they may be or already are ill. We are increasingly recognizing the necessity of being proactive in …

Overcoming the Limitations of CAR-T Therapy: Burnout

Reading time: 4 minutes Alex S. Woodell Marathon runners are an interesting breed. In order to complete the grueling 26.2 mile circuit, they must push their mental and physical boundaries to the limit. Seasoned runners possess great strength, focus, resilience, and determination. Each of these qualities is a testament to the intense training schedules they …

Robots are coming for your job (if you are a radiologist)

Reading time: 4 minutes Morgan McSweeney What can humans do better than robots? For most of history, the answer to that question has been.. everything. However, the balance of power is rapidly shifting away from warm, fleshy, humans toward cold, calculating, processing power. Did you know that a few years ago, an artificial intelligence (AI) …

Estrogen on the Brain: How Hormones Might Be Increasing Brain Metastasis

Reading time: 3 minutes Sara Musetti One of the realities of cancer is that the primary tumor is rarely the cause of issues; usually, mortality and complications come from tumor cells spreading throughout the body and forming new tumors, a process called metastasis. For most cancers, the primary tumor can be surgically removed, but once …